Skip to main content

Advertisement

Table 1 The tumor sample distribution of the 649 microarrays with corresponding controls among the tumor classes and tumor entities used in our analysis

From: The functional cancer map: A systems-level synopsis of genetic deregulation in cancer

Tumor class Tumor entity Analyzed Controls Number of Samples
Blood Acute Lymphoblastic Leukemia Peripheral Blood, Grade Pre-B Stratagene 9
Bone marrow Acute Lymphoblastic Leukemia Bone Marrow, Grade Common Stratagene 35
Bone marrow Acute Lymphoblastic Leukemia Bone Marrow, Grade Pre-B Stratagene 33
Bone Extraskeletal Myxoid Chondrosarcoma CRH 10
Breast Breast Carcinoma Stratagene 94
Breast Breast Carcinoma Invasive Ductal Carcinoma, Grade 2 Stratagene 31
Breast Breast Carcinoma Invasive Ductal Carcinoma, Grade 3 Stratagene 19
Breast Breast Carcinoma Invasive Lobular Carcinoma, Grade 2 Stratagene 19
Liver Human Hepatocellular Carcinoma Stratagene 19
Lymhpocytes Follicular Lymphoma CRG 24
Mixture Solitary Fibrous Tumor CRG 7
Muscle Leiomyosarcoma CRG 7
Ovarian Ovarian Carcinoma CRD 39
Pancreas Adenocarcinoma, Pancreas CRH 10
Pancreas Adenocarcinoma, Pancreas, Grade II CRH 5
Pancreas Adenocarcinoma, Pancreas, Grade III CRH 6
Prostate Prostate Tumor, Grade T2b Stratagene 23
Prostate Prostate Tumor, Grade T3a Stratagene 19
Prostate Prostate Tumor, Grade T3b Stratagene 9
Renal Conventional Renal Cell Carcinoma, Grade 1 Stratagene 9
Renal Conventional Renal Cell Carcinoma, Grade 2 Stratagene 34
Renal Conventional Renal Cell Carcinoma, Grade 3 Stratagene 94
Renal Conventional Renal Cell Carcinoma, Grade 4 Stratagene 40
Skin Dermatofibrosarcoma Protuberans CRG 6
Soft Tissue Synovial Sarcoma CRG 5
Stomach Stomach Cancer Before Treatment CRF 14
Stomach Stomach Cancer, Placebo After 1 Year CRF 13
Testis Testis Seminoma CRG 16